MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Jasper Therapeutics, Inc. (JSPRW)
Jasper Therapeutics, Inc. (JSPRW)
source: myfinsight.com
Net decrease in
cash, cash...
-$14,548K
Stock-based compensation
expense
$423K
Non-cash lease expense
$185K
Accrued expenses and
other current...
$55K
Other non-current
assets
-$36K
Depreciation and
amortization expense
$21K
Net cash used in
operating activities
-$14,548K
Canceled cashflow
$720K
Change in fair value of
warrant liability
-$9,640K
Accounts payable
-$3,781K
Net loss
-$1,174K
Operating lease liability
-$478K
Prepaid expenses and
other current assets
$195K
Back